Indonesia Bariatric Surgery Devices Market Analysis

Indonesia Bariatric Surgery Devices Market Executive Summary

The Indonesia Bariatric Surgery Devices Market is at around $16 Mn in 2023 and is projected to reach $22.8 Mn in 2030, exhibiting a CAGR of 5.2% during the forecast period 2023-2030.

Making modifications to your digestive system in order to aid in weight loss is the goal of gastric bypass and other weight-loss surgeries, also referred to as bariatric or metabolic surgery. When diet and exercise have not resolved your weight-related health issues, bariatric surgery is performed. Certain diet plans restrict the amount of food you can consume. Some functions through diminishing the body's capacity to assimilate calories and fat. Certain techniques provide both functions. While bariatric surgery can offer many benefits, all forms of weight-loss surgery are major procedures that can pose risks and side effects. Also, you must make permanent healthy changes to your diet and get regular exercise to help ensure the long-term success of bariatric surgery. Bariatric surgery is done to help you lose extra weight and reduce your risk of possibly life-threatening weight-related health problems, including: certain cancers, including breast, endometrial and prostate cancer, heart disease and stroke, high blood pressure, high cholesterol levels, Non-alcoholic fatty liver disease (NAFLD) or non-alcoholic steatohepatitis (NASH), sleep apnoea, type 2 diabetes etc.

According to Global Obesity Observatory 2023, the women are more prone to obesity than men, in women the prevalence is 4.5% and men it is 1.3%. Therefore, the market is driven by various factors such as increasing demand for minimally invasive surgeries, rising incidence of obesity, technological advancements, rising awareness about bariatric surgery.

The prominent players in the market are Medtronic, B. Braun, Asenus Surgical, Johnson & Johnson, Cousin Surgery among others.

Market Dynamics

Market Drivers

Rising obesity rates in Indonesia: According to Global Obesity Observatory 2023, the women are more prone to obesity than men, in women the prevalence is 4.5% and men it is 1.3%. This trend is likely to continue, creating a larger potential patient pool for bariatric surgeries and driving demand for related devices.

Awareness of Health Risks: Growing public awareness about the serious health risks associated with obesity, including the development of chronic diseases, is motivating individuals to consider bariatric surgery as a viable option. Educational campaigns highlighting the links between obesity and chronic diseases are encouraging more patients to explore surgical weight-loss options, thereby boosting the market for bariatric devices.

Technological Advancements: Advances in surgical techniques and medical devices are making bariatric procedures safer and more effective, encouraging more patients to opt for these surgeries. Thus, enhancing the market size.

Market Restraints

Shortage of Qualified Surgeons: There are limited number of trained and experienced bariatric surgeons in certain regions, particularly in rural or underserved areas. This shortage restrict access to quality surgical care for patients with chronic diseases. Thus, limiting the market growth rate.

Potential complications and risks of surgical procedures: Like any major surgery, bariatric procedures carry risks such as infection, bleeding, and adverse reactions to anaesthesia. Long-term complications like nutritional deficiencies and dumping syndrome can also occur. These risks deter some patients from pursuing surgical options.

Economic Factors: Economic instability or downturns can lead to reduced disposable income for patients, making elective procedures like bariatric surgery less accessible. This can negatively affect the market for bariatric devices.

Regulatory Landscape and Reimbursement Scenario

Ministry of Health (Kementerian Kesehatan) is the primary regulatory authority responsible for overseeing healthcare policies and regulations, including those related to medical devices and bariatric surgery. The National Agency of Drug and Food Control (BPOM - Badan Pengawas Obat dan Makanan) is responsible for the regulation, including approval and safety monitoring, of medical devices used in bariatric surgery.

The National Health Insurance program (JKN - Jaminan Kesehatan Nasional), managed by BPJS Kesehatan (Badan Penyelenggara Jaminan Sosial Kesehatan), is the primary public health insurance system. Its policies significantly influence the reimbursement landscape for medical procedures, including bariatric surgery.

The Indonesian Medical Association (IDI - Ikatan Dokter Indonesia) plays a role in setting professional standards and guidelines for medical procedures, including bariatric surgery. The Indonesian Association for the Study of Obesity (IASO - Perhimpunan Studi Obesitas Indonesia) provides guidelines and recommendations for obesity treatment, including surgical interventions. The National Committee for Medical Device Evaluation (KKPAN - Komite Kajian Produk Alat Kesehatan Nasional) advises on the evaluation and use of medical devices in the country.

Regarding reimbursement, it's important to note that coverage for bariatric surgery in Indonesia is limited. The JKN program primarily focuses on essential health services, and bariatric surgery is often considered an elective procedure. Many patients rely on private insurance or out-of-pocket payments for these procedures.

Competitive Landscape

Key Players

Here are some of the major key players in the Indonesia Bariatric Surgery Devices Market:

• Medtronic plc.
• Ethicon, Inc. (Johnson & Johnson)
• Asenus Surgical US, Inc.
• B Braun Melsungen AG
• Cousin Surgery
• Olympus Corporation
• Richard Wolf GmbH
• SPATZ FIGA, Inc.
• Teleflex Incorporated
• USGI Medical, Inc.